Best in Biotech 3 Aug 2020 Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity In the fight against shrinking biodiversity, biotechnology could be a lifesaver. These European biotech initiatives are making a difference for wildlife biodiversity worldwide. Human activity is having a massive impact on wildlife biodiversity. According to a global study, 75% of terrestrial ecosystems and 66% of marine ecosystems are severely altered. This threatens the extinction of […] August 3, 2020 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jun 2020 UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the manufacturing efficiency of human cells for use in cell therapy and drug discovery. The impressive deal brings Bit Bio’s total funding to €44.4M since it was spun off from the University of Cambridge in 2016. It’s the second-largest Series A […] June 16, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2020 AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest strategic alliance in European biotech in 2020. The partners aim to commercialize three phase I-stage antibody drugs for undisclosed types of solid and liquid cancer. Upfront, the US AbbVie will pay the Danish biotech €659M, with up to €2.77B available […] June 11, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2020 Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step closer to commercializing the first vaccine to protect humans against equine encephalitis, a mosquito-borne infection that has been explored for use as a bioweapon. The trial was fully funded by the US Department of Defense. The vaccine was well-tolerated and […] June 9, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by PCMG 8 Jun 2020 Why Biotechs Should Invest in Good Outsourcing Management of CROs The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs is seen as a standard in the drug development industry. However, the management of drug development partners and providers can be highly challenging for biotechs. This is where outsourcing expertise can make the difference between […] June 8, 2020 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 8 Jun 2020 Regulations on Genetic Data Could Threaten Genomics Innovation As genetic research relies more and more on digital technology, international regulations are straining to catch up and some fear they threaten to stifle innovation. Is it possible to develop a regulatory framework for genetic data that is fair for everyone? In just a couple decades, the digital revolution has taken over all sorts of […] June 8, 2020 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 13 Apr 2020 Need Funding to Fight Coronavirus? These Initiatives Have You Covered As coronavirus disease continues to take its devastating toll across the globe, there is a clear need for new strategies to curb it. Thankfully, initiatives are springing up around the world that can support European startups in the search for new methods of diagnosis, treatment, and prevention. Coronavirus disease, also known as Covid-19, is wreaking […] April 13, 2020 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2020 Novacyt Launches Two-Hour Coronavirus Test After FDA Approval The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing and distribution partnerships across Europe. The test received an Emergency Use Authorization from the FDA, which means it can only be […] March 26, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 25 Mar 2020 DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback French biotech DBV Technologies’ bid for the US approval of a skin patch to treat nut allergies could be delayed as the FDA requested more information on the patch’s efficacy. Specifically, the FDA requested more information on patch-site adhesion – critical to the patch working effectively – as well as its long-term efficacy. According to […] March 25, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2020 LSP Raises €528M in Largest European Life Sciences Investment Fund Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated to new medicines and technologies after raising €528M. LSP 6, the company’s largest private equity fund to date, attracted significantly more than the original €396M target from a diverse investor group that included governments and the EU-supported European Investment Fund. […] March 10, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2020 Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […] March 4, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2020 CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout UK cell culture specialist CN Bio Innovations has secured €7.98M (£7M) from Chinese investors to bolster its US market and expand European activities. Investment in the bioengineering company was led by Chinese investor CITIC Securities Company and with further support from existing Hong Kong-based investor CN Innovations Holdings. CN Bio, which creates benchtop instruments to […] March 4, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email